Related Experiment Videos

Salbutamol vs. placebo for treatment of pertussis

Pediatric Infectious Disease
|November 1, 1985
PubMed

Insights

This study found that salbutamol did not significantly impact the severity or course of whooping cough in hospitalized children. The bronchodilator showed no benefits for treating this respiratory illness in young patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Whooping cough (pertussis) is a serious respiratory infection in infants and children.
  • Convulsive stage of whooping cough presents significant clinical challenges.
  • Bronchodilators are sometimes considered for respiratory symptom management.

Purpose of the Study:

  • To evaluate the efficacy of salbutamol in treating hospitalized children with whooping cough.
  • To determine if salbutamol alters the course or severity of pertussis in the convulsive stage.

Main Methods:

  • Double-blind, placebo-controlled, crossover study design.
  • Inclusion of nine hospitalized children aged 1.5 to 27 months with confirmed whooping cough.
  • Standardized supplementary treatment and standard salbutamol dosage.

Main Results:

  • Salbutamol administration yielded no statistically significant effect on whooping cough outcomes.
  • No discernible difference in disease course or severity was observed between salbutamol and placebo groups.
  • The bronchodilator did not demonstrate efficacy in this pediatric cohort.

Conclusions:

  • Salbutamol is not effective for managing whooping cough in hospitalized children during the convulsive stage.
  • Further research may be needed to explore alternative therapeutic strategies for severe pertussis.
  • Current findings do not support the use of salbutamol for this indication.

Related Concept Videos